We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Visual Prosthesis Learns to Identify Implant Signals

By HospiMedica staff writers
Posted on 01 May 2007
A new software system improves the function of retinal implants by "teaching” a visual prosthesis to generate signals that can be correctly interpreted by the brain.

Neural computation scientists at Bonn University (Germany) developed the Retina Encoder, a computer program that converts the camera signals and forwards them to the retinal implant. More...
The encoder, which is being tested on sighted volunteers, learns in a continuous process how to change the camera output signal so that the respective patient can perceive the image. Initially, the Retina Encoder does not know which language the individual's virtual central visual system "speaks.” Therefore, the software translates the original picture--for example, a ring--in different, randomly selected dialects. The volunteer sees these variations on a small screen that is integrated in a frame of glasses. By means of head movements, he selects those variations that appear most similar to a ring.

From these choices, the learning software draws conclusions on how to improve the translation. In the next learning cycle, several new improved picture variations are presented, which are already more similar to the original: during this process, the Retina Encoder becomes adapted step-by-step to the language of the virtual central visual system. In normally sighted humans, a kind of natural retina encoder is already integrated in the retina: specifically, four layers of nerve cells are positioned in front of the photoreceptor cells.

The scientists added that in the brain, the complex information is decoded, and the brain acquires the corresponding ability within the first months of life. During this time, the central visual system becomes individually adjusted to the retinal signals: the brain learns how to interpret the data from the optic nerve. In adults, however, who become blind later in life, the central visual system has already matured, and is not as flexible.

"The retina is a transparent biocomputer,” said Prof. Rolf Eckmiller, from the department of computer science at Bonn University. "It transforms the electrical signals of rod and cone photoreceptors into a complex signal. This signal reaches the brain via the optic nerve. The artificial retina must learn to generate signals that are useful for the brain.”


Related Links:
Bonn University

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.